Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianping Lan

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Bone Marrow Transplantation|May 25, 2021
Comparison of non-first-degree related donors and first-degree related donors in haploidentical HSCT: a multi-centre retrospective analysisYishan Ye, Mowang Wang, Florent Malard, et al.
Hematological Oncology|May 30, 2020
Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher-risk myelodysplastic syndromes: a prospective multicenter single-arm trialXinping Zhou, Chen Mei, Jin Zhang, et al.
Cancer|February 5, 2024
Comparison of long-term outcomes between imatinib and dasatinib prophylaxis after allogeneic stem cell transplantation in patients with Philadelphia-positive acute lymphoblastic leukemia: A multicenter retrospective studyFangshu Guan, Luxin Yang, Yi Chen, et al.
The Lancet. Haematology|August 6, 2019
A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trialZhiling Yan, Jiang Cao, Hai Cheng, et al.
Oncoimmunology|April 14, 2017
Combining therapeutic antibodies using basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease: A multi-center prospective studyYamin Tan, Haowen Xiao, Depei Wu, et al.
American Journal of Hematology|February 18, 2022
Safety and efficacy of a humanized CD19 chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic leukemiaMing Shi, Li Li, Shiyuan Wang, et al.
British Journal of Haematology|June 11, 2025
EASIX score predicts non-relapse mortality and severe infection in elderly patients undergoing allo-HSCTLizhen Liu, Shipei Xiang, Junjie Cao, et al.
Bone Marrow Transplantation|November 8, 2024
Mismatched unrelated donors allogeneic hematopoietic stem cell transplantation with antithymocyte globulin for hematological malignancies: a multicenter retrospective study in ChinaLin Li, Yi Chen, Ting Chen, et al.
Frontiers in Oncology|July 14, 2022
A Novel Prognostic Scoring Model for Myelodysplastic Syndrome Patients With <i>SF3B1</i> MutationLiya Ma, Bin Liang, Huixian Hu, et al.
Bone Marrow Transplantation|December 3, 2024
Better pre-transplant treatment options for TP53-mutated MDS: cytoreductive or non-cytoreductive therapy?Bingqian Jiang, Tingting Yang, Yanmin Zhao, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Bone Marrow Transplantation|May 25, 2021
Comparison of non-first-degree related donors and first-degree related donors in haploidentical HSCT: a multi-centre retrospective analysisYishan Ye, Mowang Wang, Florent Malard, et al.
Hematological Oncology|May 30, 2020
Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher-risk myelodysplastic syndromes: a prospective multicenter single-arm trialXinping Zhou, Chen Mei, Jin Zhang, et al.
Cancer|February 5, 2024
Comparison of long-term outcomes between imatinib and dasatinib prophylaxis after allogeneic stem cell transplantation in patients with Philadelphia-positive acute lymphoblastic leukemia: A multicenter retrospective studyFangshu Guan, Luxin Yang, Yi Chen, et al.
The Lancet. Haematology|August 6, 2019
A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trialZhiling Yan, Jiang Cao, Hai Cheng, et al.
Oncoimmunology|April 14, 2017
Combining therapeutic antibodies using basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease: A multi-center prospective studyYamin Tan, Haowen Xiao, Depei Wu, et al.
American Journal of Hematology|February 18, 2022
Safety and efficacy of a humanized CD19 chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic leukemiaMing Shi, Li Li, Shiyuan Wang, et al.
British Journal of Haematology|June 11, 2025
EASIX score predicts non-relapse mortality and severe infection in elderly patients undergoing allo-HSCTLizhen Liu, Shipei Xiang, Junjie Cao, et al.
Bone Marrow Transplantation|November 8, 2024
Mismatched unrelated donors allogeneic hematopoietic stem cell transplantation with antithymocyte globulin for hematological malignancies: a multicenter retrospective study in ChinaLin Li, Yi Chen, Ting Chen, et al.
Frontiers in Oncology|July 14, 2022
A Novel Prognostic Scoring Model for Myelodysplastic Syndrome Patients With <i>SF3B1</i> MutationLiya Ma, Bin Liang, Huixian Hu, et al.
Bone Marrow Transplantation|December 3, 2024
Better pre-transplant treatment options for TP53-mutated MDS: cytoreductive or non-cytoreductive therapy?Bingqian Jiang, Tingting Yang, Yanmin Zhao, et al.
Pageof 6